Prostate-Specific Antigen (PSA): Clinical Applications in Prostate Cancer Screening (continued)

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 183 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
The page below is a sample from the LabCE course Tumor Markers. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Tumor Markers (online CE course)
Prostate-Specific Antigen (PSA): Clinical Applications in Prostate Cancer Screening (continued)

The reason that PSA must be carefully interpreted in combination with clinical symptoms is that the subsequent testing to follow up on an elevated PSA is costly, surgically invasive, and often met with a high degree of anxiety.
The procedure to biopsy the prostate gland to confirm or rule out a diagnosis of prostate cancer is not without its risks and complications, including injury to adjacent tissues of the bladder and urethra, and may leave moderate to long-term effects of impotence.